Target intelligence / Profile preview

Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids (DNA/RNA)

Target
DNA/RNA
Molecular classification
Nucleic acid, Biopolymer, Other
01

Overview

Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids are the primary carriers of genetic information, essential for the replication, growth, and function of all known living organisms and many viruses [NIH, 2023]. In a therapeutic context, these molecules are targeted by a wide array of pharmacological agents, particularly in the treatment of cancer and infectious diseases, where disrupting the integrity of the genetic template can halt uncontrolled cell division [PubChem, 2024]. Common mechanisms of action include DNA alkylation, where drugs form covalent bonds with nucleic acid bases, and intercalation, where planar molecules slide between base pairs to disrupt the double helix structure [StatPearls, 2023]. Additionally, antimetabolites can be incorporated into the growing DNA or RNA strand, leading to chain termination or the production of non-functional genetic material [PubMed, 2022]. Because these targets are fundamental to all dividing cells, drugs that interact with DNA often exhibit significant side effects, such as bone marrow suppression and potential secondary malignancies [Wikipedia, 2024]. Recent advancements also focus on the polyanionic nature of nucleic acids to develop targeted delivery systems for gene therapies and antisense oligonucleotides [Nature, 2023].

Other names
Nucleic acidsPolynucleotidesGenetic materialPolyanionic biopolymersGenomic DNA
02

Mechanism of action

DNA alkylation, intercalation, covalent cross-linking, and inhibition of synthesis or repair through antimetabolite incorporation

03

Biological functions

Genetic information storageReplicationTranscriptionTranslationProtein synthesisOther
04

Disease associations

CancerViral infectionBacterial infectionGenetic disorderOther
05

Safety considerations

MyelosuppressionSecondary malignanciesTeratogenicityInfertilityCardiotoxicityMutagenicity
06

Interacting drugs

Cisplatin

7 more in the full profile.

07

Biomarkers

gamma-H2AX (DNA damage marker)Circulating tumor DNA (ctDNA)Microsatellite instability (MSI)Tumor mutational burden (TMB)8-hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids (DNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxyribonucleic acid (DNA) and other polyanionic nucleic acids (DNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call